Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Sacco

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Future Oncology (London, England)|February 5, 2014
Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapyLorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, et al.
Cells|December 24, 2021
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver DiseaseDaryl Ramai, Antonio Facciorusso, Erika Vigandt, et al.
Expert Review of Anticancer Therapy|November 22, 2015
Curative therapies for hepatocellular carcinoma: an update and perspectivesRodolfo Sacco, Michela Antonucci, Giampaolo Bresci, et al.
Expert Opinion on Drug Safety|May 9, 2019
Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysisGiovanni Galati, Moises Muley, Mauro Viganò, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Virology|December 17, 2003
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNaseRodolfo Sacco, Takeya Tsutsumi, Ryosuke Suzuki, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Journal of Imaging|November 26, 2024
Bright Luminal Sign on High b-Value Diffusion-Weighted Magnetic Resonance Enterography Imaging as a New Biomarker to Predict Fibrotic Strictures in Crohn's Disease Patients: A Retrospective Preliminary StudyLuca Pio Stoppino, Stefano Piscone, Ottavia Quarta Colosso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2021
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysisAntonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, et al.
Cancers|March 11, 2023
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular CarcinomaLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Future Oncology (London, England)|February 5, 2014
Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapyLorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, et al.
Cells|December 24, 2021
Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver DiseaseDaryl Ramai, Antonio Facciorusso, Erika Vigandt, et al.
Expert Review of Anticancer Therapy|November 22, 2015
Curative therapies for hepatocellular carcinoma: an update and perspectivesRodolfo Sacco, Michela Antonucci, Giampaolo Bresci, et al.
Expert Opinion on Drug Safety|May 9, 2019
Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysisGiovanni Galati, Moises Muley, Mauro Viganò, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015 - part 2Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Virology|December 17, 2003
Antiapoptotic regulation by hepatitis C virus core protein through up-regulation of inhibitor of caspase-activated DNaseRodolfo Sacco, Takeya Tsutsumi, Ryosuke Suzuki, et al.
Future Oncology (London, England)|January 19, 2016
The calm before the storm: a report from the International Liver Cancer Association Congress 2015--part 1Giuseppe Cabibbo, Maria Reig, Gennaro Gadaleta-Caldarola, et al.
Journal of Imaging|November 26, 2024
Bright Luminal Sign on High b-Value Diffusion-Weighted Magnetic Resonance Enterography Imaging as a New Biomarker to Predict Fibrotic Strictures in Crohn's Disease Patients: A Retrospective Preliminary StudyLuca Pio Stoppino, Stefano Piscone, Ottavia Quarta Colosso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 1, 2021
Efficacy of combined transarterial radioembolization and sorafenib in the treatment of hepatocarcinoma: A meta-analysisAntonio Facciorusso, Rosa Paolillo, Nicola Tartaglia, et al.
Cancers|March 11, 2023
Prognostic Impact of Metastatic Site in Patients Receiving First-Line Sorafenib Therapy for Advanced Hepatocellular CarcinomaLuca Ielasi, Francesco Tovoli, Matteo Tonnini, et al.
Pageof 17